Older patients with mantle cell lymphoma who are unfit for standard immunochemotherapy have generally poor outcomes when treated with low-intensity regimens instead, a new study shows. An “attenuated” regimen of low-intensity immunochemotherapy is often offered in older, unfit MCL patients, but outcomes with such an approach have been relatively unexplored, says researchers from the UK. ...
‘Unsatisfactory’ outcomes for older patients with Mantle cell lymphoma
17 May 2021